Global Blood Gas Analyzer Market – Industry Trends and Forecast to 2030

Blood Gas Analyzer Market Analysis and Size

The elderly population is at higher risk of contracting infectious diseases and need continuous monitoring to avoid health complications. In this regards, these analyzers come in. The growing demand for technologically advanced combined systems and reduction of point of care blood gas analyzer is actively enhancing the growth of the market. Numerous companies are investing in developing and marketing these products.

Data Bridge Market Research analyses that the blood gas analyzer market was valued at USD 668.4 million in 2022 and is expected to reach USD 995.08 million by 2030, growing at a CAGR of 5.10% from 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Blood Gas Analyzer Market Scope and Segmentation  

Market Definition

The blood gas analyzers are widely utilized to measure electrolyte, pH, blood gas, and some metabolites in the whole blood specimen. Some of the common blood gas analyzers will measure lactate, glucose, and bilirubin. These measurements show the build-up or breakdown of chemical components in the body, representing pulmonary status or disease condition.

Blood Gas Analyzer Market Dynamics

Drivers

• Growing Elderly Population

The elderly population is at more risk of contracting infectious diseases; thus, they require uninterrupted monitoring of their vital signs while treatment to prevent critical health complications. For instance, as per the World Population Ageing Highlight 2020, the global elderly population is growing rapidly worldwide and in 2020, around 727 million people of age 65 years or more were living all over the world which was around 9.3% of the total global population and also, the same source anticipated that the population of people of aged 65 years or more will be around 1.5 billion people by the end of 2050 which will be a total of 16% of global population. Likewise, as per the October 2021 update of WHO, the total percentage of people of age more than 60 years in the global population will rise from 12% in 2015 to 22% by 2050, of which, around 80% of the older people in 2050 will be living in the low-and middle-income countries.

Opportunities

• Increasing Advantages of Blood Gas Analyzers

As per the National Heart, Lung and Blood Institute Atherosclerotic Risk in Communities (ARIC) study and Cardiovascular Health Study (CHS) in 2021, there are around 1,260,000 new and recurrent coronary attacks every yearabout 37% of people experience a coronary attack in a year and eventually die from it. Using these blood gas analyzers will help determine a patient's disease and help avoid such critical conditions leading to market growth.

• Growing Product Launches

The growing product launches and collaborations are boosting the growth of the market. For instance, ENVEA launched its new portable multi-gas monitor MIR 9000P in January 2021 designed to meet the precise needs of regulatory and periodic MIR 9000P and is compliant with international directives such as United States Environmental Protection Agency and EN 15267-4. It guarantees increased accuracy and prolonged measuring ranges for 8 parameters namely NOx, N2O, CO, CO2, SO2, CH4, O2 and residual H2O. Thus, these kind of launches are driving the market growth.

Restraints/Challenges

• High Cost of Analyzers

The increased cost of these analyzers are acting as a restraint in the market growth. Not all the instruments can be afforded by the lower economic group; therefore, it can prevent them from availing these analyzers despite being so useful.

This blood gas analyzer market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the blood gas analyzer market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Blood Gas Analyzer Market

The COVID-19 pandemic has affected majorly the healthcare industry. During the pandemic, numerous surgeries were delayed, and non-emergency hospitalizations was canceled which impacted the market. The percentage of infectious disease-related visits was four times higher during the early pandemic period. Though, a steep rise was observed in the hospitalization rate of people suffering from COVID-19. Increasing cases of the COVID-19 pandemic have driven the demand for blood gas and electrolyte analyzers in clinics, hospitals,  and point-of-care centers and positively boosted the industry growth.

Recent Developments

• In 2022, Sysmex America Inc. received FDA clearance for the development of a new feature to its N-10 Automated Hematology Analyzer with Blood Bank mode. This is the first automated analyzer that is approved for residual WBC counting.
• In 2021, Siemens healthiness launched the epoc Blood Analysis System. It is a handheld, wireless solution having complete blood gas, hematocrit and lactate on a single room temperature-stable test card, a basic metabolic panel, delivering patient-side results in less than 1 minute. It helps in supporting COVID-19 response efforts, where blood gas testing plays a serious role in managing infected patients.

Global Blood Gas Analyzer Market Scope

The blood gas analyzer market is segmented on the basis of product type, modality and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type  

• i-Stat
• ePOC
• GEM Premier
• ABL Flex
• Cobas,
• RAPID Series
• Others

 Modality

• Portable
• Bench-top

Distribution Channel

• Hospital, Diagnostics Centers
• Clinics
• Ambulatory Surgical Centers
• Educational Institutes
• Others

Blood Gas Analyzer Market Regional Analysis/Insights

The blood gas analyzer market is analyzed and market size insights and trends are provided by product type, modality and distribution channel as referenced above.

The countries covered in the blood gas analyzer market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the blood gas analyzer market because of the better healthcare infrastructure, rising demand for point of care devices combined with high adoption of electronic and technologically advanced health instruments in the region

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 because of the increasing awareness of technologically advanced analyzers and growing expenditure on healthcare industry in this particular region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The blood gas analyzer market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for blood gas analyzer market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the blood gas analyzer market. The data is available for historic period 2011-2021.

Competitive Landscape and Blood Gas Analyzer Market Share Analysis

The blood gas analyzer market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to blood gas analyzer market.

Some of the major players operating in the blood gas analyzer market are:

• Abbott (U.S.)
• Dalko diagnostics (India)
• EDAN Instruments, Inc.(China)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Instrumentation laboratory (U.S.)
• Radiometer (Denmark)
• Siemens Healthcare GmbH (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• TECOM Analytical Systems (Austria)
• OPTI MEDICAL SYSTEMS (U.S.)
• Erba Mannheim (Germany)
• Medica Corporation (U.S.)
• Alere Inc (U.S.)

SKU-57320